Application of topological descriptors in QSAR and drug design: history and new trends.
about
On the evolution of the standard amino-acid alphabetThe role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systemsGlobal Model for Octanol-Water Partition Coefficients from Proton Nuclear Magnetic Resonance Spectra.Chemical properties of air pollutants and cause-specific hospital admissions among the elderly in Atlanta, GeorgiaIn silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.Databases and QSAR for cancer research.Molecular topology as a novel approach for drug discovery.Ionic channels as targets for drug design: a review on computational methods.Prediction of pharmacokinetic parameters using a genetic algorithm combined with an artificial neural network for a series of alkaloid drugs.History of EPI Suite™ and future perspectives on chemical property estimation in US Toxic Substances Control Act new chemical risk assessments.QSAR, DFT and molecular modeling studies of peptides from HIV-1 to describe their recognition properties by MHC-I.Models for antitubercular activity of 5â-O-[(N-Acyl)sulfamoyl]adenosines.A quantitative structure-activity relationship study on serotonin 5-HT6) receptor ligands: indolyl and piperidinyl sulphonamides.On some novel extended topochemical atom (ETA) parameters for effective encoding of chemical information and modelling of fundamental physicochemical properties.Search of chemical scaffolds for novel antituberculosis agents.Modelling of Hydrophilic Interaction Liquid Chromatography Stationary Phases Using Chemometric Approaches.Predictability and prediction of lowest observed adverse effect levels in a structurally heterogeneous set of chemicals.On Eccentricity-Based Topological Indices Study of a Class of Porphyrin-Cored Dendrimers
P2860
Q21184155-6DBB3F41-3BF9-4EFE-8588-E7CDB0801588Q28388493-2F0871F9-DEA4-4A7E-BC1C-B20D2374EC96Q31119234-0A6EDC1E-05B8-4754-927F-E56A30DB81BDQ35591851-2A132DC9-1282-4239-A4C5-9E28123023D8Q36840592-158B83FF-F7C0-48BF-901D-01DD3F5163FBQ37175028-36074CF8-4781-41B9-9A51-4C9A80F08062Q37999095-88F6E421-4797-46C0-970C-5DF427E6DF00Q38168995-FA3EE187-C109-43F4-82C6-040914613DB9Q38258986-3FCFDE06-7FB6-4C2E-B16E-29C547A50E86Q38748527-371F47D9-157E-4BA9-AFBF-8DF95A4332F6Q40110552-3D278235-D1F7-4FD8-8F08-3694689F6AFDQ41376285-D15BE5BA-029F-4591-88C3-D38BCC75528BQ43026448-E13DD949-8835-470A-ABD2-9DE41F94BF60Q44372955-C8F1F926-71CA-4F9F-AA0D-E5D8245C1BE8Q46421304-F0A84FCB-1160-4DA0-BEBA-393379FAFF15Q47100262-0B79E738-9EDC-4441-A1C5-0F766743EDBAQ50770260-FA7D6437-850C-4221-BCFE-E58967DDFCFAQ58796584-9B778A7D-3152-4C4C-886D-6DCC31ADC330
P2860
Application of topological descriptors in QSAR and drug design: history and new trends.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Application of topological descriptors in QSAR and drug design: history and new trends.
@ast
Application of topological descriptors in QSAR and drug design: history and new trends.
@en
type
label
Application of topological descriptors in QSAR and drug design: history and new trends.
@ast
Application of topological descriptors in QSAR and drug design: history and new trends.
@en
prefLabel
Application of topological descriptors in QSAR and drug design: history and new trends.
@ast
Application of topological descriptors in QSAR and drug design: history and new trends.
@en
P2093
P356
P1476
Application of topological descriptors in QSAR and drug design: history and new trends.
@en
P2093
P304
P356
10.2174/1568005024605909
P577
2002-03-01T00:00:00Z